Literature DB >> 27045883

Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.

Kyla A McKay1, Shayesteh Jahanfar2, Tom Duggan1, Stacey Tkachuk1, Helen Tremlett3.   

Abstract

Multiple sclerosis (MS) is a chronic disease of the central nervous system with an unidentified etiology. We systematically reviewed the literature on the possible risk factors associated with MS disease onset, relapses and progression from 1960 to 2012 by accessing six databases and including relevant systematic reviews, meta-analyses, case-control or cohort studies. The focus was on identifying modifiable risk factors. Fifteen systematic reviews and 169 original articles were quality assessed and integrated into a descriptive review. Best evidence, which included one or more prospective studies, suggested that lower exposure to sunlight and/or lower serum vitamin D levels were associated with an increased risk of developing MS onset and subsequent relapses, but a similar quality of evidence was lacking for disease progression. Prospective studies indicated that cigarette smoking may increase the risk of MS as well as accelerate disease progression, but whether smoking altered the risk of a relapse was largely unknown. Infections were implicated in both risk of developing MS and relapses, but data for progression were lacking. Specifically, exposure to the Epstein-Barr virus, particularly if this manifested as infectious mononucleosis during adolescence, was associated with increased MS risk. Upper respiratory tract infections were most commonly associated with an increase in relapses. Relapse rates typically dropped during pregnancy, but there was no strong evidence to suggest that pregnancy itself altered the risk of MS or affected long-term progression. Emerging research with the greatest potential to impact public health was the suggestion that obesity during adolescence may increase the risk of MS; if confirmed, this would be of major significance.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Etiology; Multiple sclerosis; Progression; Relapses; Risk factors; Systematic review

Mesh:

Year:  2016        PMID: 27045883     DOI: 10.1016/j.neuro.2016.03.020

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  30 in total

Review 1.  The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings.

Authors:  Helen Tremlett; Emmanuelle Waubant
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

2.  Effects of physical comorbidities on disability progression in multiple sclerosis.

Authors:  Tingting Zhang; Helen Tremlett; Feng Zhu; Elaine Kingwell; John D Fisk; Virender Bhan; Trudy Campbell; Karen Stadnyk; Robert Carruthers; Christina Wolfson; Sharon Warren; Ruth Ann Marrie
Journal:  Neurology       Date:  2018-01-03       Impact factor: 9.910

Review 3.  Evaluating the Effects of Dietary Interventions on Disease Progression and Symptoms of Adults with Multiple Sclerosis: An Umbrella Review.

Authors:  Abbey R Tredinnick; Yasmine C Probst
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 4.  Comorbidity in multiple sclerosis: implications for patient care.

Authors:  Ruth Ann Marrie
Journal:  Nat Rev Neurol       Date:  2017-03-17       Impact factor: 42.937

5.  Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.

Authors:  Kaarina Kowalec; Kyla A McKay; Scott B Patten; John D Fisk; Charity Evans; Helen Tremlett; Ruth Ann Marrie
Journal:  Neurology       Date:  2017-11-08       Impact factor: 9.910

Review 6.  Immunoneuropsychiatry - novel perspectives on brain disorders.

Authors:  Marion Leboyer; Frauke Zipp; Katrin Pape; Ryad Tamouza
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

7.  Associations between smoking and walking, fatigue, depression, and health-related quality of life in persons with multiple sclerosis.

Authors:  Turhan Kahraman; Asiye Tuba Ozdogar; Zuhal Abasiyanik; Serkan Ozakbas
Journal:  Acta Neurol Belg       Date:  2020-03-28       Impact factor: 2.396

Review 8.  Lower prevalence of multiple sclerosis in First Nations Canadians.

Authors:  Ruth Ann Marrie; Stella Leung; Nancy Yu; Lawrence Elliott
Journal:  Neurol Clin Pract       Date:  2018-02

Review 9.  The multiple sclerosis prodrome.

Authors:  Naila Makhani; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2021-06-21       Impact factor: 42.937

Review 10.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.